Home Stock

Stock Research: Fresenius Medical Care

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Fresenius Medical Care

GER:FME DE0005785802
49
  • Value
    100
  • Growth
    27
  • Safety
    Safety
    44
  • Combined
    65
  • Sentiment
    28
  • 360° View
    360° View
    49
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Fresenius Medical Care AG is a Germany-based kidney dialysis institute providing dialysis care and related services for end-stage renal disease (ESRD) and other extracorporeal therapies. It operates in healthcare services, including R&D, manufacturing, supply chain, and commercial operations, developing both dialysis and non-dialysis products. In the last fiscal year, the company had a market cap of $15757 million, profits of $4925 million, revenue of $20019 million, and 111513 employees.

more

ANALYSIS: With an Obermatt 360° View of 49 (better than 49% compared with alternatives), overall professional sentiment and financial characteristics for the stock Fresenius Medical Care are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Fresenius Medical Care. Only the consolidated Value Rank has an attractive rank of 100, which means that the share price of Fresenius Medical Care is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 100% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 27, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 44, meaning the company has a riskier financing structure than 56% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 72% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 28. ...read more

more
Strongest Rank Analyst Opinions
Weakest Rank Value
Country Germany
Industry Health Care Services
Size X-Large
Website freseniusmedicalcare.com
Index
CDAX
DAX 40
Fresenius Medical Care stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 3-Sep-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
100 88 83 89
Growth
27 38 31 27
Safety
Safety
44 61 74 41
Sentiment
28 58 23 9
360° View
360° View
49 81 54 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
3 13 8 21
Opinions Change
38 65 53 29
Pro Holdings
n/a 51 24 46
Market Pulse
39 81 64 34
Sentiment
28 58 23 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
100 88 83 89
Growth
27 38 31 27
Safety Safety
44 61 74 41
Combined
65 83 82 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
82 69 72 75
Price vs. Earnings (P/E)
84 77 77 89
Price vs. Book (P/B)
89 82 84 84
Dividend Yield
87 77 74 84
Value
100 88 83 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
12 29 10 32
Profit Growth
88 39 8 6
Capital Growth
26 42 82 84
Stock Returns
41 82 83 27
Growth
27 38 31 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
34 31 38 24
Refinancing
86 77 77 47
Liquidity
41 42 42 39
Safety Safety
44 61 74 41

Similar Stocks

Discover high‑ranked alternatives to Fresenius Medical Care and broaden your portfolio horizons.

Fresenius

GER:FRE
Country: Germany
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

Henkel

GER:HEN3
Country: Germany
Industry: Household Products
Size: X-Large
Full Stock Analysis

Deutsche Telekom

GER:DTE
Country: Germany
Industry: Integrated Telecommunication
Size: XX-Large
Full Stock Analysis

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The only strength is good value. All other factors (growth, safety, and sentiment) are below average. This stock is highly sensitive to a crisis and is not advisable. Avoid unless you have solid, independent reasons to believe a significant turnaround is imminent.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews